Medicare Enrolled
Dr. Norman Welch, M.D.
Endocrinology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Welch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Welch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Welch
Dr. Norman Welch is an endocrinology specialist in Atlanta, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Welch performed 4,196 Medicare services across 1,181 unique beneficiaries.
Between the years covered by Open Payments, Dr. Welch received a total of $27,634 from 85 pharmaceutical and/or device companies across 1298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Welch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 14% volume in GA
$27,634 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,196
Medicare services
Top 14% in GA for endocrinology
1,181
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~200 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,220 | $18 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $86 | $270 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
246 | $9 | $50 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
207 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
176 | $63 | $200 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
174 | $10 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
106 | $16 | $78 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
91 | $13 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
89 | $11 | $125 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
82 | $38 | $200 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
80 | $8 | $45 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
65 | $39 | $95 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
62 | $25 | $110 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
61 | $8 | $40 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
49 | $3 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $62 | $175 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
39 | $6 | $105 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
35 | $5 | $35 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
34 | $9 | $50 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
23 | $25 | $165 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $10 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,634
Total received (2018-2024)
Avg $3,948/year across 7 years
Top 13% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
1,298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,372 (84.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,262 (15.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,258
2023
$3,025
2022
$3,694
2021
$3,384
2020
$4,462
2019
$3,597
2018
$6,215
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$333
Novo Nordisk Inc
$296
Lilly USA, LLC
$256
Novartis Pharmaceuticals Corporation
$229
Xeris Pharmaceuticals, Inc.
$218
Abbott Laboratories
$215
Dexcom, Inc.
$208
Medtronic, Inc.
$193
Corcept Therapeutics
$193
Amneal Pharmaceuticals LLC
$151
BETA BIONICS, INC.
$123
Radius Health, Inc.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Madrigal Pharmaceuticals
$98
SANOFI-AVENTIS U.S. LLC
$86
Embecta Corp.
$80
CeQur Corporation
$48
Mannkind Corporation
$39
Esperion Therapeutics, Inc.
$36
Chiesi USA, Inc.
$34
Astellas Pharma US Inc
$30
Insulet Corporation
$28
Nevro Corp.
$24
Averitas Pharma Inc.
$23
Neurocrine Biosciences, Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
IBSA Pharma Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
ABBVIE INC.
$13
Top 3 companies account for 27.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,952
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,777
Lilly USA, LLC
$1,784
Amgen Inc.
$1,757
SANOFI-AVENTIS U.S. LLC
$1,677
Tandem Diabetes Care, Inc.
$1,615
Corcept Therapeutics
$1,204
Abbott Laboratories
$1,136
Insulet Corporation
$1,061
AstraZeneca Pharmaceuticals LP
$836
Amarin Pharma Inc.
$826
Xeris Pharmaceuticals, Inc.
$825
Medtronic, Inc.
$620
Amneal Pharmaceuticals LLC
$523
Radius Health, Inc.
$477
Novartis Pharmaceuticals Corporation
$438
Dexcom, Inc.
$397
Valeritas, Inc.
$372
Mannkind Corporation
$363
Zealand Pharma US, Inc.
$305
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$302
Janssen Pharmaceuticals, Inc
$283
AbbVie Inc.
$266
IBSA Pharma Inc.
$247
Medtronic MiniMed, Inc.
$244
Becton, Dickinson and Company
$241
Bigfoot Biomedical Inc
$239
GRT US Holding, Inc.
$194
Endo Pharmaceuticals Inc.
$184
AbbVie, Inc.
$179
Senseonics, Incorporated
$158
CeQur Corporation
$151
Esperion Therapeutics, Inc.
$147
Alexion Pharmaceuticals, Inc.
$131
BETA BIONICS, INC.
$123
VistaPharm, Inc.
$115
LifeScan, Inc.
$110
KVK-Tech, Inc.
$110
Companion Medical, Inc.
$110
Bayer HealthCare Pharmaceuticals Inc.
$107
Shire North American Group Inc
$103
MannKind Corporation
$101
PFIZER INC.
$98
Madrigal Pharmaceuticals
$98
Embecta Corp.
$96
Clarus Therapeutics Inc.
$92
Ipsen Biopharmaceuticals, Inc
$91
Merck Sharp & Dohme LLC
$90
Merck Sharp & Dohme Corporation
$87
Eisai Inc.
$80
Intuity Medical Inc
$79
Nalpropion Pharmaceuticals LLC
$68
Averitas Pharma Inc.
$66
Currax Pharmaceuticals LLC
$62
Ascensia Diabetes Care US Inc.
$55
ABBVIE INC.
$55
Acerus Pharmaceuticals Corporation
$49
Orexigen Therapeutics, Inc.
$45
Ultragenyx Pharmaceutical Inc.
$41
Nalpropion Pharmaceuticals, Inc.
$39
Nevro Corp.
$38
Aytu BioScience, Inc
$37
Horizon Therapeutics plc
$37
Chiesi USA, Inc.
$34
Astellas Pharma US Inc
$30
RECORDATI_RARE_DISEASES_INC.
$29
Strongbridge US INC.
$28
DEXCOM, INC.
$27
Daiichi Sankyo Inc.
$24
Genentech USA, Inc.
$22
Azurity Pharmaceuticals, Inc.
$21
Neurocrine Biosciences, Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Nestle HealthCare Nutrition Inc.
$20
Sun Pharmaceutical Industries Inc.
$20
Horizon Pharma plc
$17
Antares Pharma, Inc.
$17
VIVUS LLC
$15
IDORSIA PHARMACEUTICALS US INC
$15
Roche Diabetes Care, Inc.
$14
Ferring Pharmaceuticals Inc.
$13
VIVUS, Inc.
$13
Ascensia Diabetes Care Us Inc.
$13
Aegerion Pharmaceuticals, Inc.
$12
EISAI INC.
$12
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Adthyza · Aimovig · Androgel · BAQSIMI · BD 6cess · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BEVESPI AEROSPHERE · Belviq · CONTOUR NEXT ONE Meter · CONTRAVE · CREON · CYCLOSET · Cables · CeQur Simplicity · Creon · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · EDEX · ELIQUIS · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · Kits and Accessories · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · LYRICA · LYUMJEV · Lenvima · MACRILEN · MINIMED 780G · MOUNJARO · MYALEPT · Macrilen · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Natesto · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QUTENZA · QUVIVIQ · Qsymia · Qutenza · RAYOS · RECORLEV · RESMETIROM · RIOMET ER · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Software · Sogroya · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · Vabysmo · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZOMACTON · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
102
Per 100K population
9.5
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Welch is a mixed practice specialist, with above-average Medicare volume (top 14% in GA), with low-engagement industry engagement in the top 13% of GA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Welch experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Welch performed 2,220 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Welch receive payments from pharmaceutical companies?
Yes. Dr. Welch received a total of $27,634 from 85 companies across 1,298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Welch's costs compare to other endocrinologists in Atlanta?
Dr. Welch's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Welch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Atlanta
Browse endocrinologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology